US$ 27.86
bpc-157 market size as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC-157 For Knee Pain: Early
Description
Injectable BPC-157 for Injury Recovery and Targeted Support Subcutaneous injections are often considered the commonly used when higher systemic availability is desired
If a patient has low bone density, anabolic agents such as teriparatide, abaloparatide, or romosozumab may be utilized to stimulate bone formation pre-operatively to ensure the spine is strong enough to hold the new hardware

Composition Active Ingredient: Adenosine Triphosphate Disodium Trihydrate 10.98 mg/mL (Equivalent to 10 mg ATP per 2 mL ampoule) Form: Injectable solution for intramuscular (IM) or slow intravenous (IV) use Effects & Benefits Enhances cellular energy production and metabolism Improves blood circulation and oxygen delivery Aids in fatigue recovery and physical performance Supports cardiac function and muscle recovery May be used in treatment of chronic fatigue, poor peripheral circulation, or during rehabilitation therapies Sometimes used in aesthetic medicine as part of energy-boosting or anti-aging treatments Usage Administered only by medical professionals Cautions: Should be used with caution in patients with heart conditions or hypotension
However, caution should be exercised when using the 1-inch needle, as accurately determining the midpoint for insertion is subjective and susceptible to error
